+674.0%
MRNA vs GNRC
+253.5%
+420.6%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GNRC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.9% | +2.5% | +4.6% |
| 7D | -1.1% | -0.2% | -0.9% | -1.0% |
| 30D | +126.1% | -15.7% | +141.9% | +137.1% |
| 3M | +190.0% | -27.3% | +217.4% | +212.8% |
| 6M | +157.2% | -12.1% | +169.3% | +159.7% |
| YTD | +388.2% | +37.1% | +351.1% | +326.9% |
| 1Y | +467.0% | -0.5% | +467.5% | +441.6% |
| 3Y | +36.1% | +61.5% | -25.4% | +10.4% |
| 5Y | -68.0% | -58.6% | -9.4% | -65.7% |
| All | +674.0% | +253.5% | +420.6% | +424.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GNRC.
Daily Out/Under-Performance
Portfolio return minus GNRC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GNRC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GNRC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling